Powder: -20°C for 3 years | In solvent: -80°C for 1 year
'(Ala13)-Apelin-13 TFA acts as a potent antagonist of the apelin receptors (APJ) and impedes gastric motility via the vagal cholinergic pathway [1].'
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | '(Ala13)-Apelin-13 TFA acts as a potent antagonist of the apelin receptors (APJ) and impedes gastric motility via the vagal cholinergic pathway [1].' |
In vivo | (Ala13)-Apelin-13 TFA, microinjected into the DVC at doses ranging from 1-300 pmol/60 nl, dose-dependently reduces gastric tension and motility in rats [1]. |
Molecular Weight | 1474.73 (free acid) |
Formula | C63H107N23O16S.xC2HF3O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(Ala13)-Apelin-13 TFA inhibitor inhibit